Latent Tuberculosis Treatment With 4 Months of Rifampin Compared to 9 Months of Isoniazid

    loading  Checking for direct PDF access through Ovid

Abstract

In an open-label trial, adults with latent tuberculosis infection were randomized to either four months of treatment with rifampin or nine months of treatment with isoniazid. The four-month rifampin regimen was non-inferior to nine months of isoniazid for prevention of active tuberculosis.

Related Topics

    loading  Loading Related Articles